STOCK TITAN

The Campbell's Company Financials

CPB
Source SEC Filings (10-K/10-Q) Updated Mar 11, 2026 Currency USD FYE August

This page shows The Campbell's Company (CPB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 43 / 100
Financial Profile 43/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
47

The Campbell's Company has an operating margin of 11.0%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 47/100, indicating healthy but not exceptional operating efficiency. This is up from 10.4% the prior year.

Growth
44

The Campbell's Company's revenue grew 6.4% year-over-year to $10.3B, a solid pace of expansion. This earns a growth score of 44/100.

Leverage
71

The Campbell's Company carries a low D/E ratio of 1.54, meaning only $1.54 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
11

The Campbell's Company's current ratio of 0.82 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 11/100, which could limit financial flexibility.

Cash Flow
42

The Campbell's Company has a free cash flow margin of 6.9%, earning a moderate score of 42/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
45

The Campbell's Company's ROE of 15.2% shows moderate profitability relative to equity, earning a score of 45/100. This is up from 14.8% the prior year.

Altman Z-Score Distress
1.67

The Campbell's Company scores 1.67, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Strong
7/9

The Campbell's Company passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.88x

For every $1 of reported earnings, The Campbell's Company generates $1.88 in operating cash flow ($1.1B OCF vs $602.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
3.3x

The Campbell's Company earns $3.3 in operating income for every $1 of interest expense ($1.1B vs $345.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$10.3B
YoY+6.4%
5Y CAGR+3.4%
10Y CAGR+2.4%

The Campbell's Company generated $10.3B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA
$1.6B
YoY+10.4%
5Y CAGR+1.7%
10Y CAGR+1.4%

The Campbell's Company's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.4% from the prior year.

Net Income
$602.0M
YoY+6.2%
5Y CAGR-18.0%
10Y CAGR-1.0%

The Campbell's Company reported $602.0M in net income in fiscal year 2025. This represents an increase of 6.2% from the prior year.

EPS (Diluted)
$2.01
YoY+6.3%
5Y CAGR-17.8%
10Y CAGR-0.6%

The Campbell's Company earned $2.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$705.0M
YoY+5.5%
5Y CAGR-8.5%
10Y CAGR-1.6%

The Campbell's Company generated $705.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.5% from the prior year.

Cash & Debt
$168.0M
YoY-79.2%
5Y CAGR-25.3%
10Y CAGR-4.4%

The Campbell's Company held $168.0M in cash against $6.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.54
YoY+4.1%
5Y CAGR+1.9%
10Y CAGR+2.1%

The Campbell's Company paid $1.54 per share in dividends in fiscal year 2025. This represents an increase of 4.1% from the prior year.

Shares Outstanding
298M
YoY-0.0%
5Y CAGR-0.3%
10Y CAGR-0.4%

The Campbell's Company had 298M shares outstanding in fiscal year 2025. This represents a decrease of 0.0% from the prior year.

Margins & Returns

Gross Margin
30.4%
YoY-0.4pp
5Y CAGR-4.1pp
10Y CAGR-4.0pp

The Campbell's Company's gross margin was 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin
11.0%
YoY+0.6pp
5Y CAGR-1.8pp
10Y CAGR-2.1pp

The Campbell's Company's operating margin was 11.0% in fiscal year 2025, reflecting core business profitability. This is up 0.6 percentage points from the prior year.

Net Margin
5.9%
YoY-0.0pp
5Y CAGR-12.9pp
10Y CAGR-2.4pp

The Campbell's Company's net profit margin was 5.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.

Return on Equity
15.2%
YoY+0.5pp
5Y CAGR-43.6pp
10Y CAGR-31.9pp

The Campbell's Company's ROE was 15.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the prior year.

Capital Allocation

R&D Spending
$100.0M
YoY-2.0%
5Y CAGR+1.5%
10Y CAGR-1.6%

The Campbell's Company invested $100.0M in research and development in fiscal year 2025. This represents a decrease of 2.0% from the prior year.

Share Buybacks
$62.0M
YoY-7.5%
10Y CAGR-12.8%

The Campbell's Company spent $62.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 7.5% from the prior year.

Capital Expenditures
$426.0M
YoY-17.6%
5Y CAGR+7.3%
10Y CAGR+1.1%

The Campbell's Company invested $426.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.6% from the prior year.

CPB Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue $2.6B0.0% $2.6B-4.2% $2.7B+10.8% $2.4B-2.4% $2.5B-7.8% $2.7B-3.1% $2.8B+20.9% $2.3B
Cost of Revenue $1.8B0.0% $1.8B-2.0% $1.9B+15.2% $1.6B-6.4% $1.7B-6.4% $1.9B-2.0% $1.9B+17.7% $1.6B
Gross Profit $717.0M0.0% $717.0M-9.5% $792.0M+1.5% $780.0M+7.1% $728.0M-11.1% $819.0M-5.5% $867.0M+28.4% $675.0M
R&D Expenses $22.0M0.0% $22.0M-8.3% $24.0M-14.3% $28.0M+21.7% $23.0M-8.0% $25.0M-3.8% $26.0M0.0% $26.0M
SG&A Expenses $160.0M0.0% $160.0M-4.2% $167.0M-7.2% $180.0M+11.1% $162.0M-1.8% $165.0M-5.7% $175.0M-3.8% $182.0M
Operating Income $273.0M0.0% $273.0M-18.8% $336.0M+12.0% $300.0M+86.3% $161.0M-50.8% $327.0M-10.9% $367.0M+376.6% $77.0M
Interest Expense $82.0M0.0% $82.0M+1.2% $81.0M-11.0% $91.0M+7.1% $85.0M-3.4% $88.0M+1.1% $87.0M+3.6% $84.0M
Income Tax $48.0M0.0% $48.0M-22.6% $62.0M+44.2% $43.0M+186.7% $15.0M-79.7% $74.0M+12.1% $66.0M+2300.0% -$3.0M
Net Income $145.0M0.0% $145.0M-25.3% $194.0M+14.8% $169.0M+156.1% $66.0M-61.8% $173.0M-20.6% $218.0M+7366.7% -$3.0M
EPS (Diluted) $0.480.0% $0.48-26.2% $0.65 N/A $0.22-62.1% $0.58-19.4% $0.72 N/A

CPB Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $15.3B0.0% $15.3B+1.1% $15.2B+1.9% $14.9B+0.5% $14.8B-6.8% $15.9B-1.3% $16.1B+5.8% $15.2B
Current Assets $2.7B0.0% $2.7B+6.5% $2.6B+14.8% $2.2B+0.3% $2.2B-30.0% $3.2B+1.4% $3.1B+43.2% $2.2B
Cash & Equivalents $561.0M0.0% $561.0M+233.9% $168.0M+27.3% $132.0M-7.7% $143.0M-82.8% $829.0M+2.6% $808.0M+648.1% $108.0M
Inventory $1.4B0.0% $1.4B-9.6% $1.5B+5.7% $1.4B+10.0% $1.3B+0.5% $1.3B-8.8% $1.4B+1.9% $1.4B
Accounts Receivable N/A N/A N/A $541.0M N/A N/A N/A $587.0M
Goodwill $5.0B0.0% $5.0B0.0% $5.0B0.0% $5.0B0.0% $5.0B+0.1% $5.0B-1.3% $5.1B-0.4% $5.1B
Total Liabilities $11.3B0.0% $11.3B+1.1% $11.2B+2.1% $11.0B+0.3% $11.0B-8.7% $12.0B-2.2% $12.3B+7.2% $11.4B
Current Liabilities $2.7B0.0% $2.7B-14.1% $3.1B+7.7% $2.9B+2.0% $2.8B-16.5% $3.4B-1.5% $3.5B-3.1% $3.6B
Long-Term Debt $6.6B0.0% $6.6B+9.0% $6.1B0.0% $6.1B0.0% $6.1B-6.1% $6.5B-3.1% $6.7B+16.4% $5.8B
Total Equity $4.0B0.0% $4.0B+1.2% $4.0B+1.4% $3.9B+0.8% $3.9B-1.0% $3.9B+1.8% $3.8B+1.3% $3.8B
Retained Earnings $4.8B0.0% $4.8B+0.6% $4.8B+1.6% $4.7B+0.6% $4.7B-1.1% $4.7B+1.2% $4.7B+2.0% $4.6B

CPB Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow $515.0M-0.2% $516.0M+130.4% $224.0M-13.5% $259.0M+91.9% $135.0M-73.6% $512.0M+127.6% $225.0M-21.9% $288.0M
Capital Expenditures $117.0M+17.0% $100.0M-21.3% $127.0M-2.3% $130.0M+52.9% $85.0M-15.8% $101.0M-8.2% $110.0M-22.0% $141.0M
Free Cash Flow $398.0M-4.3% $416.0M+328.9% $97.0M-24.8% $129.0M+158.0% $50.0M-87.8% $411.0M+257.4% $115.0M-21.8% $147.0M
Investing Cash Flow -$187.0M-92.8% -$97.0M+29.2% -$137.0M-28.0% -$107.0M-212.6% $95.0M+174.2% -$128.0M-172.3% -$47.0M+66.7% -$141.0M
Financing Cash Flow -$601.0M-2125.9% -$27.0M+47.1% -$51.0M+68.9% -$164.0M+82.1% -$915.0M-152.1% -$363.0M-169.4% $523.0M+460.7% -$145.0M
Dividends Paid $121.0M+3.4% $117.0M-2.5% $120.0M+3.4% $116.0M0.0% $116.0M+4.5% $111.0M-4.3% $116.0M+4.5% $111.0M
Share Buybacks -$28.0M-1500.0% $2.0M-91.7% $24.0M+1100.0% $2.0M-50.0% $4.0M+100.0% $2.0M-96.3% $54.0M+157.1% $21.0M

CPB Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin 28.0%0.0pp 28.0%-1.6pp 29.6%-2.7pp 32.3%+2.9pp 29.4%-1.1pp 30.5%-0.8pp 31.3%+1.8pp 29.4%
Operating Margin 10.7%0.0pp 10.7%-1.9pp 12.6%+0.1pp 12.4%+5.9pp 6.5%-5.7pp 12.2%-1.1pp 13.2%+9.9pp 3.4%
Net Margin 5.7%0.0pp 5.7%-1.6pp 7.2%+0.2pp 7.0%+4.3pp 2.7%-3.8pp 6.4%-1.4pp 7.9%+8.0pp -0.1%
Return on Equity 3.6%0.0pp 3.6%-1.3pp 4.9%+0.6pp 4.3%+2.6pp 1.7%-2.7pp 4.4%-1.2pp 5.7%+5.8pp -0.1%
Return on Assets 0.9%0.0pp 0.9%-0.3pp 1.3%+0.2pp 1.1%+0.7pp 0.4%-0.6pp 1.1%-0.3pp 1.4%+1.4pp -0.0%
Current Ratio 1.010.0 1.01+0.2 0.82+0.1 0.77-0.0 0.78-0.2 0.93+0.0 0.91+0.3 0.61
Debt-to-Equity 1.660.0 1.66+0.1 1.54-0.0 1.56-0.0 1.58-0.1 1.66-0.1 1.75+0.2 1.52
FCF Margin 15.5%-0.7pp 16.2%+12.6pp 3.6%-1.7pp 5.3%+3.3pp 2.0%-13.3pp 15.3%+11.2pp 4.2%-2.3pp 6.4%

Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

The Campbell's Company (CPB) reported $10.3B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

The Campbell's Company (CPB) revenue grew by 6.4% year-over-year, from $9.6B to $10.3B in fiscal year 2025.

Yes, The Campbell's Company (CPB) reported a net income of $602.0M in fiscal year 2025, with a net profit margin of 5.9%.

The Campbell's Company (CPB) reported diluted earnings per share of $2.01 for fiscal year 2025. This represents a 6.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Campbell's Company (CPB) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, The Campbell's Company (CPB) had $168.0M in cash and equivalents against $6.1B in long-term debt.

The Campbell's Company (CPB) had a gross margin of 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

The Campbell's Company (CPB) had an operating margin of 11.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

The Campbell's Company (CPB) had a net profit margin of 5.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, The Campbell's Company (CPB) paid $1.54 per share in dividends during fiscal year 2025.

The Campbell's Company (CPB) has a return on equity of 15.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

The Campbell's Company (CPB) generated $705.0M in free cash flow during fiscal year 2025. This represents a 5.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

The Campbell's Company (CPB) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

The Campbell's Company (CPB) had $15.2B in total assets as of fiscal year 2025, including both current and long-term assets.

The Campbell's Company (CPB) invested $426.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

The Campbell's Company (CPB) invested $100.0M in research and development during fiscal year 2025.

Yes, The Campbell's Company (CPB) spent $62.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

The Campbell's Company (CPB) had 298M shares outstanding as of fiscal year 2025.

The Campbell's Company (CPB) had a current ratio of 0.82 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

The Campbell's Company (CPB) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

The Campbell's Company (CPB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

The Campbell's Company (CPB) has an Altman Z-Score of 1.67, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has an earnings quality ratio of 1.88x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) has an interest coverage ratio of 3.3x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

The Campbell's Company (CPB) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top